Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“Authorized” Generic Deals Are Anti-Consumer, Teva Says

Executive Summary

"Authorized" generic deals are not good for consumers, Teva Group VP-North America William Fletcher maintained during a Feb. 17 earnings call

You may also be interested in...



Paraplatin Settlement Lets Teva Distribute Generic Under Bristol License

Pharmachemie will be able to distribute a generic version of Bristol-Myers Squibb's Paraplatin (carboplatin) by June 24

Paraplatin Settlement Lets Teva Distribute Generic Under Bristol License

Pharmachemie will be able to distribute a generic version of Bristol-Myers Squibb's Paraplatin (carboplatin) by June 24

Watson/P&G Macrobid “Authorized” Generic Challenged By Mylan

Mylan argues an "authorized" generic agreement between Watson and Procter & Gamble for a version of Macrobid inhibits competition

Related Content

UsernamePublicRestriction

Register

PS043368

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel